Ming-Kuei Jang

Ming-Kuei Jang, Ph.D.

Founder, Chairman, and President of Asia Operations, Tokyo, Hong Kong, Suzhou

  • CEO, Aprinoia Therapeutics
  • Neurodegeneration Consortium, MD Anderson Cancer Center, Houston
  • Associate Director, GlaxoSmithKline, Shanghai
  • Senior Research Biologist, Merck & CO, Boston
  • Postdoc in Neurophysiology at Northwestern University and Columbia University
  • Ph.D in Pharmacology and Neuroscience, Boston University
  • BS in Chemistry, National Taiwan University, Taiwan
  • Neurodegenerative diseases; synaptic functions; novel biomarker discovery